Legend Biotech Corp ADR (LEGN): Next-Year EPS Estimate 8426.45%
As of 2026-08-26, Legend Biotech Corp ADR (LEGN) has a next-year EPS growth estimate of 8426.45%. Featured in 3 EPS revision reports, most recently on 2026-04-23.
On 2026-08-19, analyst consensus for LEGN's next-year EPS growth shifted from 14867.72% to 8426.45% — a negative change of 6441.27 percentage points. The revised estimate has been sustained across 7 subsequent trading sessions. Current-year growth is projected at 99.08%.
What's Driving This
LEGN’s rise is primarily driven by a structural upward revision to its next-year EPS growth estimate,
Generated 2026-08-25 from news as of 2026-08-25
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 8426.45%
- EPS growth this year
- 99.08%
- EPS next quarter (est)
- $0.01
- Last price
- $20.75
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-08-26 | 8426.45% | 99.08% | $0.01 | $20.75 |
| 2026-08-25 | 8426.45% | 99.08% | $0.01 | $21.30 |
| 2026-08-24 | 8426.45% | 99.08% | $0.01 | $20.94 |
| 2026-08-23 | 8426.45% | 99.08% | $0.01 | $21.82 |
| 2026-08-21 | 8426.45% | 99.08% | $0.01 | $21.82 |
| 2026-08-20 | 8426.45% | 99.08% | $0.01 | $21.26 |
| 2026-08-19 | 8426.45% | 99.08% | $0.01 | $22.60 |
| 2026-08-18 | 14867.72% | 99.47% | $0.01 | $21.92 |
| 2026-08-17 | 14867.72% | 99.47% | $0.01 | $20.65 |
| 2026-08-16 | 14867.72% | 99.47% | $0.01 | $20.37 |
| 2026-08-14 | 14867.72% | 99.47% | $0.01 | $20.37 |
| 2026-08-13 | 15050.78% | 100.52% | $0.01 | $20.27 |
| 2026-08-12 | 10163.58% | 100.77% | $0.01 | $20.65 |
| 2026-08-11 | 22065.58% | 99.59% | $0.02 | $21.83 |
| 2026-08-10 | 4122.43% | 102.29% | $0.06 | $20.66 |
| 2026-08-09 | 4122.43% | 102.29% | $0.06 | $20.75 |
| 2026-08-07 | 4122.43% | 102.29% | $0.06 | $20.75 |
| 2026-08-06 | 4122.43% | 102.29% | $0.06 | $19.28 |
| 2026-08-05 | 4122.43% | 102.29% | $0.06 | $19.05 |
| 2026-08-04 | 4122.43% | 102.29% | $0.06 | $19.13 |
| 2026-08-03 | 4122.43% | 102.29% | $0.06 | $19.01 |
| 2026-08-02 | 4122.43% | 102.29% | $0.06 | $18.55 |
| 2026-07-31 | 4122.43% | 102.29% | $0.06 | $18.55 |
| 2026-07-30 | 4122.43% | 102.29% | $0.06 | $19.05 |
| 2026-07-29 | 4122.43% | 102.29% | $0.06 | $18.85 |
| 2026-07-28 | 4122.43% | 102.29% | $0.06 | $19.04 |
| 2026-07-27 | 4122.43% | 102.29% | $0.06 | $19.27 |
| 2026-07-26 | 4362.34% | 102.22% | $0.06 | $22.22 |
| 2026-07-24 | 4362.34% | 102.22% | $0.06 | $22.22 |
| 2026-07-23 | 5314.76% | 101.84% | $0.05 | $23.53 |
Reports Featuring LEGN
Recent News
Screen Performance
Aggregate stats across all 2015 tickers our top-EPS-revision screen has flagged over the past 147 days.
- Median return since detection
- +3.0%
- % of tickers in the green
- 56%
- Median return on winners
- +20.0%
- Large revisions captured
- 1609
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is Legend Biotech Corp ADR's next-year EPS growth estimate?▾
As of 2026-08-26, Legend Biotech Corp ADR (LEGN) has a next-year EPS growth estimate of 8426.45%, based on analyst consensus.
When was the latest EPS estimate revision for LEGN?▾
The most recent revision occurred on 2026-08-19, when analysts adjusted the next-year EPS growth estimate from 14867.72% to 8426.45%.
What sector and industry does Legend Biotech Corp ADR belong to?▾
Legend Biotech Corp ADR operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. LEGN appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Legend Biotech Corp ADR (LEGN) appears here because it was detected by our daily top-EPS-revision-performer screen.